Categories News Press Releases Archives 2025 June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November October September August June May March February January 2021 December November October September August May April February Dec 16 Positive Top-Line Results for Bimekizumab in Phase 3 Ankylosing Spondylitis Trial Read More Share:| | | Dec 10 UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis Read More Share:| | |